| Series |
TOPICS |
| Title |
Safety and efficacy of AJM300, an oral antagonist of α4 integrin, in induction therapy for patients with active ulcerative colitis |
| Author |
Naoki Yoshimura |
Department of Internal Medicine, Division of IBD, Tokyo Yamate Medical Center |
| Author |
Mamoru Watanabe |
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University |
| Author |
Satoshi Motoya |
Inflammatory Bowel Diseases Center, Sapporo-Kosei General Hospital |
| Author |
Keiichi Tominaga |
Department of Gastroenterology, Dokkyo Medical University |
| Author |
Katsuyoshi Matsuoka |
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University |
| Author |
Ryuichi Iwakiri |
Department of Internal Medicine and Gastrointestinal Endoscopy, Saga University |
| Author |
Kenji Watanabe |
Department of Gastroenterology, Osaka City General Hospital |
| Author |
Toshifumi Hibi |
Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| Author |
the AJM300 Study Group |
the AJM300 Study Group |
| [ Summary ] |
No Summary |